Clinical Trials Directory

Trials / Completed

CompletedNCT02135315

Intensive Arterial Pressure Control in Acute Coronary Syndrome

One-year Outcome of Intensive Versus Standard Blood Pressure Treatment in Non-ST Elevation Acute Coronary Syndrome: A Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,500 (actual)
Sponsor
University of Monastir · Academic / Other
Sex
All
Age
30 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The intensive arterial pressure control in acute coronary syndrome (ACS) during the first 24 hours can improve the prognosis in the short and long term. the study compare two treatment strategies (standard and intensive treatment) to assess their efficacy and safety in the treatment of acute coronary syndrome.

Detailed description

Acute coronary syndrome is often associated with arterial pressure elevation which are deleterious for the heart and needs urgent intervention to lower the blood pressure to the required values, however there is no clear recommendations concerning the treatment intensity in this situation. The investigators know that high arterial pressure increases the oxygen myocardial consumption and it is deleterious in acute coronary syndrome, so , it is logical to reduce intensively this pressure.

Conditions

Interventions

TypeNameDescription
DRUGIsosorbide Dinitrateadministration of continuous intravenous isosorbide dinitrate to obtain a SBP between 110 and 120 mmHg. After 2 hours from the start of treatment and if the blood pressure goal is not achieved, labetalol is used

Timeline

Start date
2014-03-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2014-05-09
Last updated
2022-08-24

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT02135315. Inclusion in this directory is not an endorsement.